Effect of Continuous Positive Airway Pressure on Airway Inflammation and Oxidative Stress in Patients with Obstructive Sleep Apnea

Background. Airway inflammation and oxidative stress may be linked in obstructive sleep apnea (OSA) patients. We determined the effectiveness of continuous positive airway pressure (CPAP) therapy in reducing fractional exhaled nitric oxide (FeNO) and malondialdehyde (MDA) levels in OSA patients. Met...

Full description

Saved in:
Bibliographic Details
Main Authors: Promsrisuk Tichanon, Khrisanapant Wilaiwan, Santamit Sopida, Pasurivong Orapin, Boonsawat Watchara, Intarapoka Banjamas
Format: Article
Language:English
Published: Wiley 2016-01-01
Series:Canadian Respiratory Journal
Online Access:http://dx.doi.org/10.1155/2016/3107324
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832553939220824064
author Promsrisuk Tichanon
Khrisanapant Wilaiwan
Santamit Sopida
Pasurivong Orapin
Boonsawat Watchara
Intarapoka Banjamas
author_facet Promsrisuk Tichanon
Khrisanapant Wilaiwan
Santamit Sopida
Pasurivong Orapin
Boonsawat Watchara
Intarapoka Banjamas
author_sort Promsrisuk Tichanon
collection DOAJ
description Background. Airway inflammation and oxidative stress may be linked in obstructive sleep apnea (OSA) patients. We determined the effectiveness of continuous positive airway pressure (CPAP) therapy in reducing fractional exhaled nitric oxide (FeNO) and malondialdehyde (MDA) levels in OSA patients. Methods. Thirteen patients with OSA and 13 normal controls were recruited. FeNO and MDA levels were measured in the controls and in OSA patients before and after three months of CPAP therapy. Results. FeNO and MDA levels were higher in the patients compared to the age and gender matched controls (FeNO: 25.9 ± 5.0 versus 17.5 ± 5.9 ppb, P<0.001; MDA: 14.6 ± 7.8 versus 2.1 ± 0.3 μmol/L, P<0.001). FeNO and MDA levels were lower post-CPAP compared to pre-CPAP (FeNO: 25.9 ± 5.0 versus 17.0 ± 2.3 ppb, P<0.001; MDA: 14.6 ± 7.8 versus 10.0 ± 6.4 μmol/L, P<0.01). Apnea-hypopnea index (15.9 ± 6.6 versus 4.1 ± 2.1/h, P<0.001) and mean arterial pressure (P<0.01) decreased following CPAP treatment. Daytime mean SpO2 (P<0.05) increased. Conclusion. Our study demonstrates that CPAP therapy yields clinical benefits by reducing upper airway inflammation and oxidative stress in OSA patients.
format Article
id doaj-art-475c610a5d9b4c62a91acf2bbf18d20e
institution Kabale University
issn 1198-2241
1916-7245
language English
publishDate 2016-01-01
publisher Wiley
record_format Article
series Canadian Respiratory Journal
spelling doaj-art-475c610a5d9b4c62a91acf2bbf18d20e2025-02-03T05:52:46ZengWileyCanadian Respiratory Journal1198-22411916-72452016-01-01201610.1155/2016/31073243107324Effect of Continuous Positive Airway Pressure on Airway Inflammation and Oxidative Stress in Patients with Obstructive Sleep ApneaPromsrisuk Tichanon0Khrisanapant Wilaiwan1Santamit Sopida2Pasurivong Orapin3Boonsawat Watchara4Intarapoka Banjamas5Department of Physiology, Faculty of Medicine, Khon Kaen University, Khon Kaen 40002, ThailandDepartment of Physiology, Faculty of Medicine, Khon Kaen University, Khon Kaen 40002, ThailandDepartment of Physiology, Faculty of Medicine, Khon Kaen University, Khon Kaen 40002, ThailandDepartment of Physiology, Faculty of Medicine, Khon Kaen University, Khon Kaen 40002, ThailandDepartment of Medicine, Faculty of Medicine, Khon Kaen University, Khon Kaen 40002, ThailandBumrungrad International Hospital, Bangkok 10110, ThailandBackground. Airway inflammation and oxidative stress may be linked in obstructive sleep apnea (OSA) patients. We determined the effectiveness of continuous positive airway pressure (CPAP) therapy in reducing fractional exhaled nitric oxide (FeNO) and malondialdehyde (MDA) levels in OSA patients. Methods. Thirteen patients with OSA and 13 normal controls were recruited. FeNO and MDA levels were measured in the controls and in OSA patients before and after three months of CPAP therapy. Results. FeNO and MDA levels were higher in the patients compared to the age and gender matched controls (FeNO: 25.9 ± 5.0 versus 17.5 ± 5.9 ppb, P<0.001; MDA: 14.6 ± 7.8 versus 2.1 ± 0.3 μmol/L, P<0.001). FeNO and MDA levels were lower post-CPAP compared to pre-CPAP (FeNO: 25.9 ± 5.0 versus 17.0 ± 2.3 ppb, P<0.001; MDA: 14.6 ± 7.8 versus 10.0 ± 6.4 μmol/L, P<0.01). Apnea-hypopnea index (15.9 ± 6.6 versus 4.1 ± 2.1/h, P<0.001) and mean arterial pressure (P<0.01) decreased following CPAP treatment. Daytime mean SpO2 (P<0.05) increased. Conclusion. Our study demonstrates that CPAP therapy yields clinical benefits by reducing upper airway inflammation and oxidative stress in OSA patients.http://dx.doi.org/10.1155/2016/3107324
spellingShingle Promsrisuk Tichanon
Khrisanapant Wilaiwan
Santamit Sopida
Pasurivong Orapin
Boonsawat Watchara
Intarapoka Banjamas
Effect of Continuous Positive Airway Pressure on Airway Inflammation and Oxidative Stress in Patients with Obstructive Sleep Apnea
Canadian Respiratory Journal
title Effect of Continuous Positive Airway Pressure on Airway Inflammation and Oxidative Stress in Patients with Obstructive Sleep Apnea
title_full Effect of Continuous Positive Airway Pressure on Airway Inflammation and Oxidative Stress in Patients with Obstructive Sleep Apnea
title_fullStr Effect of Continuous Positive Airway Pressure on Airway Inflammation and Oxidative Stress in Patients with Obstructive Sleep Apnea
title_full_unstemmed Effect of Continuous Positive Airway Pressure on Airway Inflammation and Oxidative Stress in Patients with Obstructive Sleep Apnea
title_short Effect of Continuous Positive Airway Pressure on Airway Inflammation and Oxidative Stress in Patients with Obstructive Sleep Apnea
title_sort effect of continuous positive airway pressure on airway inflammation and oxidative stress in patients with obstructive sleep apnea
url http://dx.doi.org/10.1155/2016/3107324
work_keys_str_mv AT promsrisuktichanon effectofcontinuouspositiveairwaypressureonairwayinflammationandoxidativestressinpatientswithobstructivesleepapnea
AT khrisanapantwilaiwan effectofcontinuouspositiveairwaypressureonairwayinflammationandoxidativestressinpatientswithobstructivesleepapnea
AT santamitsopida effectofcontinuouspositiveairwaypressureonairwayinflammationandoxidativestressinpatientswithobstructivesleepapnea
AT pasurivongorapin effectofcontinuouspositiveairwaypressureonairwayinflammationandoxidativestressinpatientswithobstructivesleepapnea
AT boonsawatwatchara effectofcontinuouspositiveairwaypressureonairwayinflammationandoxidativestressinpatientswithobstructivesleepapnea
AT intarapokabanjamas effectofcontinuouspositiveairwaypressureonairwayinflammationandoxidativestressinpatientswithobstructivesleepapnea